Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001384101-22-000122
Filing Date
2022-08-11
Accepted
2022-08-11 16:26:56
Documents
2
Period of Report
2022-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166024959990379.html 3  
1 FORM 3 wf-form3_166024959990379.xml 3 1689
2 EXHIBIT 24 - ELIAV BARR ex-24.htm EX-24 3856
  Complete submission text file 0001384101-22-000122.txt   7036
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Barr Eliav (Reporting) CIK: 0001940521 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36156 | Film No.: 221156273